SEC Filing Summary: Kindly MD, Inc. (NAKA)
Business Context and Reporting Period
This Form 8-K was filed by Kindly MD, Inc. (a Utah corporation) on December 12, 2025, reporting an event that occurred on December 10, 2025. The company's common stock (Symbol: NAKA) is listed on the Nasdaq Global Market, and it also has tradeable warrants (Symbol: NAKAW) listed on the OTC Pink Market. The company is classified as an emerging growth company.
Key Financial Metrics
The filing does not provide specific financial data regarding revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance status related to stock listing requirements.
Material Changes and Listing Status
On December 10, 2025, the company received a notice from Nasdaq stating that its common stock failed to comply with Listing Rule 5450(a)(1) for continued listing on the Nasdaq Global Market. The deficiency is due to the closing bid price of the common stock remaining below $1.00 per share for 30 consecutive business days. Currently, the stock continues to trade on the Nasdaq Global Market under the symbol "NAKA."
Outlook, Risks, and Management Commentary
- Compliance Period: The company has 180 calendar days (until June 8, 2026) to regain compliance. To do so, the closing bid price must be at least $1.00 per share for a minimum of 10 consecutive business days.
- Transfer Option: If compliance is not met by June 8, 2026, the company may apply to transfer to the Nasdaq Capital Market. This requires a $5,000 application fee and meeting other listing standards, excluding the minimum bid price requirement initially.
- Remedial Actions: Management intends to monitor the bid price and may consider a reverse stock split to cure the deficiency.
- Risks: There is no assurance the company will maintain its listing on the Nasdaq Global Market or successfully transfer to the Nasdaq Capital Market. Failure to regain compliance could result in delisting, though the company retains the right to appeal such a determination.
Key Facts for Investor Verification
- Verify the current closing bid price of NAKA to assess the likelihood of meeting the $1.00 threshold within the 180-day window.
- Monitor for any announcements regarding a reverse stock split or an application to transfer to the Nasdaq Capital Market.
- Confirm the status of the company's appeal rights should a delisting notice be issued after the compliance period expires.
- Note that the filing contains no new financial performance data; investors should refer to the most recent 10-K or 10-Q for financial metrics.